PPBT

Purple Biotech
PPBT

Overview Fund Trends Analyst Outlook Journalist POV

9 hedge funds and large institutions have $134K invested in Purple Biotech in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

more ownership

Funds ownership: →

less funds holding

Funds holding: →

less capital invested

Capital invested by funds: $ → $

less first-time investments, than exits

New positions opened: | Existing positions closed:

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
9
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$35.6K
2
+$19.4K
3
+$14K
4
ASN
Advisory Services Network
Georgia
+$2K

Top Sellers

1
-$106K
2
-$26K
3
-$15.8K
4
SM
Sabby Management
Florida
-$13K
5
TSS
Two Sigma Securities
New York
-$12K
Name Holding Trade Value Shares
Change 		Change in
Stake
1
$47K
2
$39K
3
$14K
4
$14K
5
$13K
6
$3K
7
$2K
8
$2K
9
–
10
–
11
–
12
–